Industrial Development Administration, Ministry of Economic Affairs

Emerging Biomedical Industry Development & Internationalization Program

新興生醫產業發展與國際化推動計畫

Industry chapter12 · Consumer Goods & Chemical Industries

Eligibility

Companies properly registered under the Company Act or Business Registration Act.

What’s offered

Provides a one-stop window for the biotech industry — 1-day intake plus 1-month case-flow service — and publishes the annual biotech industry white paper.

Key terms

One-day response
Service desk acknowledges request within one day.
One-month response
Comprehensive service response within one month.

Program structure

Biotech industry one-stop window

  • Single point of contact for biotech industry requests.
  • One-day acknowledgement; one-month resolution.

Biotech industry white paper

  • 2025 Biotech Industry White Paper
  • Includes industry development overview, talent overview, policy support, market analysis, and case studies of emerging biomedical companies.

More

  • Proactive case managementDesignated staff proactively engage, providing information, research support, and assistance with study problems through structured help formats.
  • Scope of serviceCovers intake flow, demand-driven info delivery, invitation letters, advisory provision, and resolution of commercial barriers.

Application window

Per official announcement each cycle.

Who to contact

Development Center for Biotechnology (DCB)

財團法人生物技術開發中心

Mr. Lin (蔡先生)

02-26558135

English-language application support: not confirmed. Plan to bring a Mandarin-fluent collaborator to the first conversation.

Source: 115年度產業輔導資源手冊 (FY2026 Industry Counseling Resource Handbook), Ministry of Economic Affairs, page 149. Translated and indexed by Compass Global. Verify terms with the issuing agency before applying.

← Browse all 147 programs
Emerging Biomedical Industry Development & Internationalization Program | Compass Global